Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.
about
Acute liver failure including acetaminophen overdoseZiconotide: a review of its pharmacology and use in the treatment of painFrom hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspectiveAcetaminophen-Induced Hepatotoxicity: a Comprehensive UpdateRole of endoplasmic reticulum stress in drug-induced toxicityThe Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1Alanine aminotransferase-old biomarker and new concept: a reviewEfficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trialsPathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized studyCompeting Mechanistic Hypotheses of Acetaminophen-Induced Hepatotoxicity Challenged by Virtual ExperimentsDrug-induced liver injury: recent advances in diagnosis and risk assessment.Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.Clinical trial data in support of changing guidelines in osteoarthritis treatment.Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBaseā¢.Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care centerFirst Multi-gram Preparation SCP-123, A Novel Water Soluble AnalgesicIntrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.Pharmacologic management of chronic pain.Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for PharmacistsParacetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series.A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration.Pharmacogenomics: a systems approach.Mechanisms of drug-induced liver injury: from bedside to bench.Covariates of intravenous paracetamol pharmacokinetics in adultsHost-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.Review article: prescribing medications in patients with cirrhosis - a practical guide.The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjectsEffectiveness of Chinese massage therapy (Tui Na) for chronic low back pain: study protocol for a randomized controlled trialAcetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study.Pharmacotherapy of fever control among hospitalized adult patients.Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice.Does therapeutic use of acetaminophen cause acute liver failure?Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury.Serum alanine aminotransferase elevation during 10 days of acetaminophen use in nondrinkers.Age-related changes in the hepatic pharmacology and toxicology of paracetamol.
P2860
Q24647134-A2309D80-AA58-4543-824D-499B41058B65Q24658327-0149E0B0-FF35-4BD2-B795-C306373A27EBQ26738626-22726491-4D19-4ACE-AC46-F7A3816F8B74Q26746501-0C2A0786-95A4-4E13-A666-1B57F8371429Q26765518-3CCA2898-C49C-4344-BE9D-AB039D0308F5Q26772999-07AB41C0-36A9-491B-A4F8-8FDFDCA844A2Q26799149-966F8953-1E7E-4353-8522-2B3BB3245CEEQ26828819-D9DF4C69-D1EB-4ABB-AE65-83A6F327AB16Q26998961-6D752492-5AAB-4156-845F-E2FCB5ED3036Q27690772-04FEDF6C-8D08-4188-B9B4-88AA46F299B1Q28211832-25AF11D8-8D8F-4CD1-ADCC-C420422C8C1BQ28555070-74BEA773-2148-4B81-B537-8BEFB24FA9F7Q30235089-3D43F801-BC0F-4DA9-8302-DDCCF3EFBDF1Q30241050-733913E3-F8DF-4129-925E-1C522D62505CQ30804806-B5984B31-A0E4-4B3B-8159-E872C78459D2Q30954151-3BE30391-7ED0-4C66-8335-DA12F5B90887Q33561982-3D129A83-61F0-4356-AA7D-1DDAA1EA02F3Q33623243-B8434B46-6350-4282-A08E-8D01AA8A035DQ33714926-4EE24989-4AA8-4AA5-AFF9-A29493E85D33Q33754287-5B97B623-EE64-4F6D-85A2-35F15CF92451Q33915700-4A9A63F8-94B5-464D-9D57-EE56567C15F2Q33924852-59638DA8-ABA0-4BA6-851B-783DB7DA1443Q33962491-5D849603-0CD2-42FB-9D7D-55A97E609C2FQ33987828-832DF1D0-1756-4082-85AF-64DDDB9B5FE8Q34137575-875AD7AD-0D91-4E5F-80B7-1CEB951DFAC3Q34169362-0065093C-68D7-4C34-B463-38FAF35B7B27Q34193839-176A9BA2-0A64-40CB-A702-00E42E3FA1DBQ34311685-8D174314-82AA-4B18-B0FE-A9BB3C596990Q34342554-2D66BE67-C64D-4C16-92A1-BD487E6B902FQ34347558-59421EA2-9A4B-4A6A-8BEB-00A069D2F8B7Q34474876-6868A1C2-7851-475D-A05E-1746ABF0CE44Q34491581-92E52E2F-1964-44A9-AD7E-1F871913EBD3Q34601408-05FB0701-5EC2-4F78-8A82-1BD0869D29CEQ34621396-AA67EB4A-D1AB-4845-9DDB-B8AFF007A52EQ34640445-5498D5DE-845C-4B07-AEE0-D3929684D98DQ34667824-CE705F64-B1CE-488A-A488-97E326EE6253Q34737067-14DED787-40EE-4D21-A5FF-313EC8A5C995Q35000102-212501D3-EED4-419A-8FD8-A6C2ADA6EFD9Q35101329-6004D1CA-4E25-47A6-8E65-8E8D85444CDDQ35101500-17A9C4BE-0AAE-4892-A96C-7902971CDE83
P2860
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.
description
2006 nĆ® lÅ«n-bĆ»n
@nan
2006 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¬Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2006 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¬Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2006幓ć®č«ę
@ja
2006幓č«ę
@yue
2006幓č«ę
@zh-hant
2006幓č«ę
@zh-hk
2006幓č«ę
@zh-mo
2006幓č«ę
@zh-tw
2006幓č®ŗę
@wuu
name
Aminotransferase elevations in ...... a randomized controlled trial.
@ast
Aminotransferase elevations in ...... a randomized controlled trial.
@en
Aminotransferase elevations in ...... a randomized controlled trial.
@nl
type
label
Aminotransferase elevations in ...... a randomized controlled trial.
@ast
Aminotransferase elevations in ...... a randomized controlled trial.
@en
Aminotransferase elevations in ...... a randomized controlled trial.
@nl
prefLabel
Aminotransferase elevations in ...... a randomized controlled trial.
@ast
Aminotransferase elevations in ...... a randomized controlled trial.
@en
Aminotransferase elevations in ...... a randomized controlled trial.
@nl
P2093
P356
P1476
Aminotransferase elevations in ...... a randomized controlled trial.
@en
P2093
Connie R Colonese
John T Slattery
Neil Kaplowitz
Paul B Watkins
Paul W Stewart
Salvatore V Colucci
Stephen C Harris
P356
10.1001/JAMA.296.1.87
P407
P577
2006-07-01T00:00:00Z